avoca quality consortium meeting topics, day 1 may 6

2
1 Avoca Quality Summit – Agenda – May 6, 2014 #AQCSummit2014 Consortium Members Meeting The Westin Princeton at Forrestal Village 201 Village Boulevard Princeton, NJ 08540 TOPICS MAY 6 TH 2014 Overall Theme: Progress through Collaboration – Breaking Down Silos, Advancing Technology, and Building Bridges to Patients 10:30 AM - 11:00 AM Registration and Continental Breakfast Welcome and Overview of the Day Introduction, agenda and objectives Patricia Leuchten, CEO, The Avoca Group Reducing Risk, Improving Quality, and Enhancing Efficiency in the Identification and Selection of Third Party Providers This session will share the approach and progress being pursued by the Avoca Quality Consortium to initiate a process for Pre-Qualification of third party organizations. Concepts include easy, central access to RFI and qualification information for critical to quality (CTQ) parameters for high-risk data generating niche-services. Moderated Consortium group discussion Consortium Member Assessment Results This session will share interim results from the 2014 Avoca Quality Consortium Member Assessment Survey evaluating satisfaction and perception of quality delivered from service providers for outsourced clinical programs. This year’s survey will provide longitudinal analyses comparing 2014 assessments to previous results. Moderated Questions/Answers

Upload: the-avoca-group

Post on 21-Jun-2015

687 views

Category:

Business


0 download

TRANSCRIPT

Page 1: Avoca Quality Consortium Meeting Topics, Day 1 May 6

1Avoca Quality Summit – Agenda – May 6, 2014 #AQCSummit2014

Consortium Members MeetingThe Westin Princeton at Forrestal Village

201 Village BoulevardPrinceton, NJ 08540

TOPICS MAY 6TH 2014

Overall Theme: Progress through Collaboration – Breaking Down Silos, Advancing Technology, and Building Bridges to Patients

10:30 AM - 11:00 AMRegistration and Continental Breakfast

Welcome and Overview of the Day

• Introduction, agenda and objectives • Patricia Leuchten, CEO, The Avoca Group

Reducing Risk, Improving Quality, and Enhancing Efficiency in the Identification and Selection of Third Party Providers

• This session will share the approach and progress being pursued by the Avoca Quality Consortium toinitiateaprocessforPre-Qualificationofthirdpartyorganizations.Conceptsincludeeasy,centralaccesstoRFIandqualificationinformationforcriticaltoquality(CTQ)parametersforhigh-riskdatageneratingniche-services.

• Moderated Consortium group discussion

Consortium Member Assessment Results

• This session will share interim results from the 2014 Avoca Quality Consortium Member Assessment Survey evaluating satisfaction and perception of quality delivered from service providers for outsourcedclinicalprograms.Thisyear’ssurveywillprovidelongitudinalanalysescomparing2014assessmentstopreviousresults.

• Moderated Questions/Answers

Page 2: Avoca Quality Consortium Meeting Topics, Day 1 May 6

2Avoca Quality Summit – Agenda – May 6, 2014 #AQCSummit2014

Consortium Member Breakout Sessions

• Breakout1:ModerateddiscussionofMemberexperiencesworkingwiththeQualityConsortiumbest-practice Quality Oversight Guidelines and Tools, Quality Agreement Template, and Technology EnablerwhichprovidesaccesstoConsortiumMemberdocuments.Thesessionwillbestructuredasaninteractivesession,withsponsorMembersandCROMembersworkingtogetheronatopic,questionoranissuerelatedtothetools.

• Breakout2:ModeratedExecutiveMeetinginparalleltoBreakout1

Quality Metrics and a Focus on Enhancing Outcomes

• ThissessionwillsharetherefinementandenhancementoftheConsortiummetricstaxonomyandframeworktoensureacomprehensivesetofmetricsthatarelikelytohavemeasurableimpacttotheoutcomesforqualityinclinicalprograms.ThepresentationwillprovideinformationregardingprogresswiththeConsortium’smetricsbenchmarkingstudyanddatabase,includingmethodsofmeasurementandreportingforspecificmetrics.

• Moderated Consortium group discussion

“Big Data” to Inform Decisions in Clinical Trial Execution

• This session will be an interactive discussion regarding the use of “big data” to inform decisions in clinicaltrialexecution.ThesessionwillstartwiththepresentationofAvoca’s2014industrydataandthenwillproceedtoaninteractivediscussion.

Wrap-up and Closure

• Dinner